Rafael Holdings is a company focused on the development of novel cancer therapies.
Rafael Holdings has raised $24.9M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2025.
Rafael Holdings's investors include Howard Jonas.
Rafael Holdings is headquartered in Newark, United States.
Rafael Holdings is a company focused on the development of novel cancer therapies.
Rafael Holdings is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Rafael Holdings — Funding & Investors." VCBacked, June 4, 2025, https://www.vcbacked.co/company/rafael-holdings. Accessed August 14, 2026.
VCBacked. (2025). Rafael Holdings — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/rafael-holdings
{{cite web |title=Rafael Holdings — Funding & Investors |url=https://www.vcbacked.co/company/rafael-holdings |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated